| Company Name: |
Jinan Yaoyan Pharmaceutical Co., Ltd.
|
| Tel: |
|
| Email: |
jnyaoyan@163.com |
| Products Intro: |
Product Name:(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid CAS:937395-08-9 Purity:99% HPLC Package:1,2,5 gram
|
| Company Name: |
Nanjing Meihao Pharmaceutical Technology Co., Ltd.
|
| Tel: |
meitaochem@126.com |
| Email: |
meitaochem@126.com |
| Products Intro: |
Product Name:(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid CAS:937395-08-9 Purity:99% HPLC Package:1,2,5 gram
|
| Company Name: |
JinOu Biomedical (Nanjing) Co., Ltd.
|
| Tel: |
13000000000 |
| Email: |
jinoupharma@163.com |
| Products Intro: |
Product Name:(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid CAS:937395-08-9 Purity:99% HPLC Package:100G;1KG;100KG
|
(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid manufacturers
- BX 667
-
- $1980.00 / 50mg
-
2026-04-14
- CAS:937395-08-9
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | (4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid Basic information |
| | (4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid Chemical Properties |
| Boiling point | 787.8±60.0 °C(Predicted) | | density | 1.283±0.06 g/cm3(Predicted) | | pka | 11.03±0.46(Predicted) |
| | (4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid Usage And Synthesis |
| Uses | BX 667 is an orally active reversible P2Y(12) receptor antagonist. BX 667 attenuates thrombosis[1]. | | References | [1] Wang YX, et al. A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models. Thromb Haemost. 2007 May;97(5):847-55. PMID:17479197 |
| | (4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid Preparation Products And Raw materials |
|